Aurobindo gets US nod for muscle relaxant tablet
MUMBAI, Aug 7 (Reuters) - Drug maker Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) said on Friday it had secured the U.S. Food and Drug Administration's approval to sell carisoprodol tablets in that country.
The drug is a muscle relaxant and the generic version of Meda Pharmaceuticals' Soma tablets, the company said in a statement.
(Reporting by Bharghavi Nagaraju; Editing by Sunil Nair)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
